The deal priced below last closing price of $42.88. Goldman Sachs, Morgan Stanley, BofA and JPMorgan are acting as joint book running managers for the offering.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDLN:
- Medline announces launch of secondary offering of Class A common stock
- Medline files to sell 75M shares of Class A common stock for holders
- Medline price target raised to $56 from $52 at Truist
- Conservative 2026 Guidance and Strong Segment Fundamentals Underpin Buy Rating and $53 Target for Medline
- Medline price target raised to $54 from $49 at Goldman Sachs